Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
NCT04351828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2020-04-21
Summary
Celiac disease is defined as an autoimmune enteropathy with malabsorption of gluten protein. In recent studies, it has been stated that in individuals diagnosed with celiac disease, intestinal epithelial barrier integrity is impaired. Increased zonulin concentration in blood is considered as an indicator of increased intestinal permeability.
Gluten-free diet is the only treatment of celiac disease. Adherence to gluten free diet provides decreasing of intestinal permeability however gluten free diet has different aspects on nutritional status and health related quality of life in people with celiac disease.
The aim of this study is to determine nutritional status, intestinal permeability and quality of life in people with celiac disease. In the study,it primarily hypothesized that celiac patients noncompliant to gluten-free diet may have increased circulating levels of zonulin and increased intestinal permeability compared to celiac patients compliant to gluten-free diet.
Conditions
- Celiac Disease
- Nutritional Deficiency
- Quality of Life
Interventions
- PROCEDURE
-
Blood draw once a time
Investigation of intestinal permeability by measuring serum zonulin levels in blood sample
Sponsors & Collaborators
-
Marmara University
lead OTHER
Principal Investigators
-
Yeşim Öztekin · Marmara University
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-05
- Primary Completion
- 2019-04-11
- Completion
- 2019-04-19
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Gut Permeability Assessment in Celiac and Gluten Sensitive Children
NCT02690532 ·Status: COMPLETED
-
MAgnetic Resonance Imaging in COeliac Disease
NCT02551289 ·Status: COMPLETED
-
Tissue Destruction and Healing in Celiac Disease
NCT05680012 ·Status: RECRUITING ·Phase: NA
-
The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis
NCT07166874 ·Status: RECRUITING ·Phase: NA
-
Characteristics of Anemia in Celiac Disease
NCT05172895 ·Status: COMPLETED
-
Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited
NCT03320811 ·Status: COMPLETED
-
Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet
NCT01129908 ·Status: COMPLETED
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Treatment of Mild Enteropathy Celiac Disease
NCT00628823 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.
NCT02242123 ·Status: COMPLETED
-
Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance
NCT03152279 ·Status: COMPLETED
-
Prospective Study of Undiagnosed Celiac Disease
NCT01317914 ·Status: COMPLETED ·Phase: NA
-
Impact of the Diagnosis of Celiac Disease
NCT01145287 ·Status: COMPLETED
-
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
NCT02389062 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife)
NCT06568263 ·Status: RECRUITING
-
Compliance With Gluten-Free Diet and Affecting Factors in Adolescents With Celiac Disease
NCT05474976 ·Status: COMPLETED
-
Gluten Reduction and Risk of Celiac Disease
NCT04593888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Screen-detected Celiac Disease
NCT01116505 ·Status: COMPLETED ·Phase: NA
-
Immune Responses to Gluten
NCT05209568 ·Status: RECRUITING ·Phase: NA
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Anti-Tissue Transglutaminase IgA Antibodies
NCT04019223 ·Status: UNKNOWN
-
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
NCT05530070 ·Status: RECRUITING ·Phase: NA
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
NCT07298343 ·Status: RECRUITING ·Phase: PHASE2
-
Gluten Technology and Education for Celiac Health
NCT06059716 ·Status: RECRUITING ·Phase: NA